UnicoCell Biomed Co., Ltd. (hereinafter referred to as UnicoCell), an award-winning leader in biotechnology, has once again achieved top recognition. The company’s human-derived exosomes earned the prestigious "Grand Prize" in the Best Product Category at the 23rd National Brand Yushan Awards, standing out among a fierce competition of 189 shortlisted nominations.
UnicoCell’s human-derived exosomes represent one of the very few exosome products in Taiwan approved under a special authorization by the Ministry of Health and Welfare (MOHW) for use as cosmetic ingredients. The exosomes are manufactured in compliance with pharmaceutical standards, and which are under the strict system of quality control for batch-release. UnicoCell has successfully completed pre-clinical development for degenerative retinal diseases, and had established a comprehensive foundation for future clinical trials and regulatory submission with well advocacy from product quality, safety, and efficacy.
By strictly adhering to international PIC/S GMP manufacturing guidelines and robust quality control protocols, UnicoCell ensures that its human exosome product, "UC-hEVEX," delivers outstanding purity, high bioactivity, and an uncompromised safety profile. This not only establishes a powerful competitive moat in the marketplace, but also provides the global biomedical industry with premium-grade regenerative medicine raw materials and technical solutions.
Looking to the future, UnicoCell remains dedicated to advancing the clinical translation and expanding the broad applications of stem cell and exosome technologies. Driven by its core commitment to "Innovative R&D and Quality Excellence," the company will build on its strong roots in Taiwan to expand its global footprint—ultimately enhancing human health and quality of life worldwide.
Contact: Daniel Ho
Phone: 886-2-27922699
Email: info@unicocell.com